Suppr超能文献

一项针对艾滋病毒/艾滋病感染者酒精使用障碍的适应性干预措施的整群随机对照试验方案:对酒精使用、总体功能能力、生活质量及高效抗逆转录病毒治疗依从性的影响

A cluster randomised controlled trial protocol of an adapted intervention for alcohol use disorders in people living with HIV and AIDS: impact on alcohol use, general functional ability, quality of life and adherence to HAART.

作者信息

Madhombiro Munyaradzi, Dube-Marimbe Bazondlile, Dube Michelle, Chibanda Dixon, Zunza Moleen, Rusakaniko Simbarashe, Stewart David, Seedat Soraya

机构信息

Department of Psychiatry, Parirenyatwa Group of Hospitals, University of Zimbabwe, College of Health Sciences, Mazowe Street, Box A178, Avondale, Harare, Zimbabwe.

Harare Central Hospital, Psychiatric Unit, Southerton, Harare, Zimbabwe.

出版信息

BMC Psychiatry. 2017 Jan 28;17(1):44. doi: 10.1186/s12888-017-1208-3.

Abstract

BACKGROUND

Interventions for alcohol use disorders (AUDs) in HIV infected individuals have been primarily targeted at HIV risk reduction and improved antiretroviral treatment adherence. However, reduction in alcohol use is an important goal. Alcohol use affects other key factors that may influence treatment course and outcome. In this study the authors aim to administer an adapted intervention for AUDs to reduce alcohol use in people living with HIV/AIDS (PLWHA).

METHODS

This study is a cluster randomised controlled trial at 16 HIV care clinics. A motivational interviewing and cognitive behavioural therapy based intervention for AUDs, developed through adaptation and piloted in Zimbabwe, will be administered to PLWHA with AUDs recruited at HIV clinics. The intervention will be administered over 16 sessions at 8 HIV clinics. This intervention will be compared with an equal attention control in the form of the World Health Organization Mental Health Gap Action Programme (WHO mhGAP) guide, adapted for the Zimbabwean context. General function, quality of life, and adherence to highly active antiretroviral treatment (HAART) will be secondary outcomes. Booster sessions will be administered to both groups at 3 and 6 months respectively. The primary outcome measure will be the Alcohol Use Disorder Identification Test (AUDIT) score. The World Health Organisation Disability Assessment Schedule 2.0 (WHODAS 2.0), World Health Organisation Quality of Life (WHOQoL) HIV, viral load, and CD4 counts will be secondary outcome measures. Outcome assessments will be administered at baseline, 3, 6, and 12 months. Moderating factors such as perceived social support, how people cope with difficult situations and post-traumatic exposure and experience will be assessed at baseline. Trained research assistants will recruit participants. The outcome assessors who will be trained in administering the outcome and moderating tools will be blinded to the treatment arms allocated to the participants. However, the principal investigator, participants and intervention staff will be unblinded. Data will be analysed using STATA Version 14. Primary and secondary outcomes will be measured at four time points that is; at baseline, 3, 6, and 12 months respectively. All participants will be included in the analysis of primary and secondary outcome measures. The mean AUDIT scores will be compared between groups using student t-tests. Multilevel logistic regression analysis will be performed for binominal variables and multilevel linear regression for continuous variables. Descriptive statistics will be computed for baseline and follow-up assessments.

DISCUSSION

The study will be the first to address problematic alcohol use in PLWHA in Zimbabwe. It seeks to use local resources in delivering a modified, brief, evidence-based, and culturally contextualised intervention. The study results will determine the effectiveness of adapting psychological interventions for AUDs in HIV infected adults using a task-sharing framework.

TRIAL REGISTRATION

Pan African Clinical Trial Registry, PACTR201509001211149 . Registered 22 July 2015.

摘要

背景

针对感染艾滋病毒个体的酒精使用障碍(AUDs)干预措施主要旨在降低艾滋病毒感染风险并提高抗逆转录病毒治疗的依从性。然而,减少酒精使用是一个重要目标。酒精使用会影响其他可能影响治疗过程和结果的关键因素。在本研究中,作者旨在对酒精使用障碍实施一种适应性干预措施,以减少艾滋病毒/艾滋病感染者(PLWHA)的酒精使用。

方法

本研究是一项在16家艾滋病毒护理诊所进行的整群随机对照试验。一种基于动机性访谈和认知行为疗法的酒精使用障碍干预措施,经过改编并在津巴布韦进行了试点,将应用于在艾滋病毒诊所招募的患有酒精使用障碍的艾滋病毒感染者。该干预措施将在8家艾滋病毒诊所进行16次疗程。此干预措施将与以世界卫生组织精神卫生差距行动规划(WHO mhGAP)指南为形式的同等关注对照进行比较,该指南已根据津巴布韦的情况进行了改编。一般功能、生活质量以及对高效抗逆转录病毒治疗(HAART)的依从性将作为次要结果。分别在3个月和6个月时对两组进行强化疗程。主要结局指标将是酒精使用障碍识别测试(AUDIT)分数。世界卫生组织残疾评定量表2.0(WHODAS 2.0)、世界卫生组织艾滋病毒生活质量量表(WHOQoL HIV)、病毒载量和CD4细胞计数将作为次要结局指标。结局评估将在基线、3个月、6个月和12个月时进行。在基线时将评估诸如感知到的社会支持、人们应对困难情况的方式以及创伤后暴露和经历等调节因素。经过培训的研究助理将招募参与者。对负责实施结局和调节工具的结局评估人员将隐瞒分配给参与者的治疗组。然而,主要研究者、参与者和干预工作人员将不设盲。数据将使用STATA 14版进行分析。主要和次要结局将在四个时间点进行测量,即分别在基线、3个月、6个月和12个月时。所有参与者都将纳入主要和次要结局指标的分析。将使用学生t检验比较两组之间的平均AUDIT分数。对于二项变量将进行多水平逻辑回归分析,对于连续变量将进行多水平线性回归分析。将计算基线和随访评估的描述性统计数据。

讨论

该研究将是首个解决津巴布韦艾滋病毒感染者中存在问题的酒精使用的研究。它旨在利用当地资源提供一种经过修改的、简短的、基于证据且符合文化背景的干预措施。研究结果将确定使用任务分担框架为感染艾滋病毒的成年人改编针对酒精使用障碍的心理干预措施的有效性。

试验注册

泛非临床试验注册中心,注册号PACTR201509001211149。于2015年7月22日注册。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验